Reporter

Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Biogen Idec reports death of patient on its MS pill

By , Globe Staff

The Cambridge biotech company said the patient died after getting a rare brain infection.

AbbVie terminates deal to take over Shire

By , Globe Staff

Shire is based in Ireland but has its US headquarters in Lexington.

New Cubist Pharmaceuticals chief executive will be Robert J. Perez

By , Globe Staff

The surprise move raised questions whether the Lexington company will continue to expand or succumb to a takeover.

Seven things you should know about Joel S. Marcus

By , Globe Staff

Marcus is founder, chairman, and chief executive of Alexandria Real Estate Equities.